GATEX | GCPAX | GATEX / GCPAX | |
Total Expense Ratio | 0.94 | 0.93 | 101% |
Annual Report Gross Expense Ratio | 0.98 | 1.07 | 92% |
Fund Existence | 48 years | 11 years | - |
Gain YTD | 1.227 | -0.508 | -242% |
Front Load | 6% | 6% | 100% |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.69B | 260M | 2,571% |
Annual Yield % from dividends | 0.36 | 0.46 | 80% |
Returns for 1 year | 7.84 | 6.57 | 119% |
Returns for 3 years | 34.55 | 41.80 | 83% |
Returns for 5 years | 43.46 | 68.21 | 64% |
Returns for 10 years | 61.53 | 97.06 | 63% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FIJYX | 29.22 | -0.19 | -0.65% |
Fidelity Advisor Biotechnology Z | |||
MSBQX | 11.94 | -0.15 | -1.24% |
Morgan Stanley American Resilience R6 | |||
NCIGX | 30.98 | -0.41 | -1.31% |
Nuveen International Value C | |||
MNHWX | 26.13 | -0.41 | -1.54% |
Manning & Napier Pro-Blend Max Term W | |||
RSIPX | 14.62 | -0.23 | -1.55% |
Columbia Disciplined Core Inst2 |